Company: PTHS
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001753926-25-000503
Chunk: 606

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1C
Chunk 606
---
6%

    AME Equities LLC (12) 
     369,178  
     6.1%

    Aperture Healthcare Ventures Ltd. (13) 
     444,071  
     7.4%

    Benuvia Operations, LLC (15) 
     384,226  
     6.4%

96 

    *
    Less than 1%

    (1)
    Except as otherwise
    indicated, the persons named in the table above have sole voting and investment power with respect to all shares of Common
    Stock shown as beneficially owned by them.

    (2)
    For Mr. Knuettel,
    includes 22,223 shares of Common Stock issuable upon the exercise of stock options which are exercisable for shares of Common
    Stock at a price of $22.68 per share, 2,778 shares of Common Stock issuable upon the exercise of stock options which are exercisable
    for shares of Common Stock at a price of $22.68 per share, 27,778 shares of Common Stock issuable upon the exercise of stock
    options which are exercisable for shares of Common Stock at a price of $22.68 per share, 121,500 shares of Common Stock issuable
    upon the exercise of stock options which are exercisable for shares of Common Stock at a price of $1.30 per share and 110,953
    shares held by the Lara Knuettel Revocable Trust. The option for 121,500 shares is owned by Mr. Knuettel directly and all
    other stock options are held of record by Camden. Mr. Knuettel serves as Managing Member of Camden and co-trustee, with individual
    dispositive power of the Lara Knuettel Revocable Trust, and accordingly, may be deemed to beneficially own the shares of Common
    Stock owned directly by Camden and the Lara Knuettel Revocable Trust. 

    (3)
    For Mr. Friedberg,
    includes 15,000 shares of Common Stock issuable upon the exercise stock options held by Mr. Friedberg, which are exercisable
    for shares of Common Stock at a price of $22.68 per share, a RSU for 31,934 shares and 520,711 shares of Common Stock owned
    by Balmoral Financial Group LLC (“Balmoral”). In addition, Mr. Friedberg serves as a manager